Study guide

6.3 Research Study Methodology, Literature Evaluation & Biostatistics

Certification in Infection Prevention and Control CIC®

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

0.1 About the CBIC CIC Exam & Certification Path 0.2 Exam Format, Domain Weighting & Study Strategy

2 Chapter 1: Identification of Infectious Disease Processes

1.1 Microorganisms & Microbial Pathogenesis 1.2 Diagnostic Microbiology & Laboratory Testing Methods 1.3 Infection Types & Clinical Syndromes 1.4 Antibiotic Resistance & Antimicrobial Stewardship Principles 1.5 Host Immunity, Defenses & Susceptibility Factors

3 Chapter 2: Surveillance and Epidemiologic Investigation

2.1 Surveillance System Design, Objectives & Case Definitions 2.2 Standardized NHSN Criteria for Healthcare-Associated Infections 2.3 Outbreak Investigation Methodology 2.4 Epidemiological Measures & Rates 2.5 Data Collection, Presentation, Visualization & Statistical Analysis

4 Chapter 3: Preventing and Controlling Transmission of Infectious Agents

3.1 Chain of Infection & Transmission Dynamics 3.2 Standard Precautions & Hand Hygiene Guidelines 3.3 Transmission-Based Precautions & Facility Isolation 3.4 Management of Multidrug-Resistant Organisms & High-Consequence Pathogens 3.5 Targeted Interventions & Evidence-Based Care Bundles

5 Chapter 4: Employee and Occupational Health

4.1 Healthcare Personnel Immunizations & Screening Programs 4.2 Post-Exposure Management Protocols 4.3 Occupational Safety, Work Restrictions & Fitness-for-Duty Evaluations

6 Chapter 5: Management, Leadership, and Communication

5.1 Infection Prevention Program Administration & Fiscal Impact 5.2 Infection Control Risk Assessment & Hazard Vulnerability Analysis 5.3 Policy Development, Regulatory Compliance & Public Health Reporting

7 Chapter 6: Education and Research Principles

6.1 Adult Education Principles & In-Service Training Design 6.2 Behavioral Change Models & Quality Improvement Methodology 6.3 Research Study Methodology, Literature Evaluation & Biostatistics

8 Chapter 7: Environment of Care

7.1 Environmental Surface Cleaning & Disinfection Controls 7.2 Healthcare Water Systems & Legionella Risk Management 7.3 Air Quality Controls, HVAC Systems & Construction ICRA 7.4 Regulated Medical Waste & Biohazard Disposal

9 Chapter 8: Cleaning, Sterilization, Disinfection, and Asepsis

8.1 Spaulding Classification System & Processing Workflow 8.2 Disinfection Levels & High-Level Disinfection (HLD) Monitoring 8.3 Sterilization Modalities, Chemical/Biological Indicators & Storage

6.3 Research Study Methodology, Literature Evaluation & Biostatistics

Key Takeaways Explain This Topic AI

The hierarchy of evidence ranks systematic reviews/meta-analyses and RCTs above observational designs (cohort, case-control, cross-sectional).

Hypothesis testing evaluates the null hypothesis ( H 0 H_0 H 0 ​ ), balancing Type I error (alpha, false positive) and Type II error (beta, false negative, statistical power).

p p p -values < 0.05 <0.05 < 0.05 indicate statistical significance; confidence intervals including 1.0 (for ratios) or 0 (for differences) indicate non-significant results.

Sensitivity (SNOUT) rules out disease, Specificity (SPIN) rules in disease; PPV increases directly with higher disease prevalence.

Critical appraisal requires evaluating internal validity (controlling selection, measurement, and confounding bias) and external validity (generalisability).

Last updated: July 2026

Evidence-based infection prevention relies on critical scientific evaluation and statistical literacy. The Infection Preventionist (IP) must analyze published research, assess methodological rigor, evaluate statistical significance versus clinical relevance, and apply biostatistical formulas to diagnostic testing and surveillance data.

The Hierarchy of Scientific Evidence

Scientific study designs possess varying degrees of protection against bias and confounding. The pyramid of evidence, ordered from highest to lowest strength of causality, guides clinical decision-making:

Evidence Level & Study Design Temporal Direction Key Measures of Effect Primary Advantages Major Vulnerabilities / Biases

Systematic Reviews & Meta-Analyses Retrospective summary of literature Pooled Relative Risk (RR), Pooled Odds Ratio (OR) Combines sample sizes from multiple studies to maximize statistical power and precision Subject to publication bias and heterogeneity among included primary studies.

Randomized Controlled Trials (RCTs) Prospective experimental Relative Risk (RR), Absolute Risk Reduction (ARR), NNT Randomization minimizes selection bias and confounding; gold standard for causality High cost, ethical constraints in withholding proven infection prevention measures.

Cohort Studies Prospective or Retrospective observational Relative Risk (RR), Cumulative Incidence Rate Ratio Tracks exposed vs. unexposed groups over time; excellent for measuring incidence Vulnerable to loss to follow-up, healthy worker effect, and unmeasured confounding.

Case-Control Studies Retrospective observational Odds Ratio (OR) Efficient for rare diseases or acute outbreak investigations; compares cases vs. controls High susceptibility to recall bias, selection bias, and non-comparable control groups.

Cross-Sectional Studies Snapshot / Single point in time Point Prevalence, Prevalence Odds Ratio Inexpensive and rapid; assesses overall disease burden or baseline compliance Cannot establish temporal sequence or causality (egg-or-chicken dilemma).

Case Series / Case Reports Retrospective descriptive Descriptive statistics, proportions First signal of novel pathogens or unique outbreak presentations No control group; cannot test hypotheses or establish statistical association.

Core Biostatistical Concepts & Hypothesis Testing

Interpreting research literature requires a rigorous understanding of biostatistical hypothesis testing:

Hypotheses and Errors

Null Hypothesis (H0) : The baseline assumption that no true statistical difference, association, or effect exists between comparison groups.

Alternative Hypothesis (Ha) : The claim that a true difference or effect exists between groups.

Type I Error (α / False Positive) : Rejecting the null hypothesis when it is actually true (concluding a difference exists when there is none). The standard alpha threshold is set at α = 0.05.

Type II Error (β / False Negative) : Failing to reject the null hypothesis when it is actually false (failing to detect a true clinical difference).

Statistical Power (1 - β) : The probability of correctly rejecting a false null hypothesis (detecting a true difference if one exists). Standard power is targeted at 80% (0.80) or 90%, influenced by sample size, effect size, and significance level.

p-Values and Confidence Intervals

p-Value : The probability of obtaining a test statistic at least as extreme as the observed result, assuming the null hypothesis is true. A p-value <0.05 indicates statistical significance, but does not measure the magnitude or clinical importance of the effect.

95% Confidence Interval (CI) : A range of values constructed around a point estimate that has a 95% probability of containing the true population parameter.

For ratio measures ( Relative Risk or Odds Ratio ), if the 95% CI includes 1.0 (e.g., RR = 0.85, 95% CI: 0.65-1.12), the finding is not statistically significant at the α = 0.05 level.

For difference measures ( Mean Difference ), if the 95% CI includes 0.0 , the finding is not statistically significant .

A narrower confidence interval indicates greater statistical precision, usually driven by a larger study sample size.

Diagnostic Testing Metrics & Calculations

IPs evaluate diagnostic and screening assays using four foundational biostatistical performance metrics:

Sensitivity and Specificity (Intrinsic Test Properties)

Sensitivity : The proportion of individuals with the disease who test positive: Sensitivity = True Positives (TP) True Positives (TP) + False Negatives (FN) \text{Sensitivity} = \frac{\text{True Positives (TP)}}{\text{True Positives (TP)} + \text{False Negatives (FN)}} Sensitivity = True Positives (TP) + False Negatives (FN) True Positives (TP) ​ High sensitivity minimizes false negatives. A highly sensitive test is used for screening ( SNOUT : S ensitive test N egative rules OUT ).

Specificity : The proportion of individuals without the disease who test negative: Specificity = True Negatives (TN) True Negatives (TN) + False Positives (FP) \text{Specificity} = \frac{\text{True Negatives (TN)}}{\text{True Negatives (TN)} + \text{False Positives (FP)}} Specificity = True Negatives (TN) + False Positives (FP) True Negatives (TN) ​ High specificity minimizes false positives. A highly specific test is used for confirmation ( SPIN : S pecific test P ositive rules IN ).

Predictive Values (Prevalence-Dependent Metrics)

Positive Predictive Value (PPV) : The probability that a patient with a positive test result actually has the disease: PPV = True Positives (TP) True Positives (TP) + False Positives (FP) \text{PPV} = \frac{\text{True Positives (TP)}}{\text{True Positives (TP)} + \text{False Positives (FP)}} PPV = True Positives (TP) + False Positives (FP) True Positives (TP) ​ PPV increases directly as disease prevalence increases in the population being tested.

Negative Predictive Value (NPV) : The probability that a patient with a negative test result actually is free of the disease: NPV = True Negatives (TN) True Negatives (TN) + False Negatives (FN) \text{NPV} = \frac{\text{True Negatives (TN)}}{\text{True Negatives (TN)} + \text{False Negatives (FN)}} NPV = True Negatives (TN) + False Negatives (FN) True Negatives (TN) ​ NPV decreases as disease prevalence increases .

Critical Appraisal of Infection Control Literature

When reviewing published studies to update institutional protocols, the IP conducts a critical appraisal evaluating:

Internal Validity : The degree to which the study design, execution, and analysis minimize bias and confounding within the sample.

Selection Bias : Non-random sampling or systematic differences between comparison groups.

Measurement / Information Bias : Misclassification of exposures or outcomes (e.g., unblinded assessors evaluating surgical site infections).

Confounding : A distortion caused by a third variable associated with both the exposure and outcome (controlled via restriction, matching, stratification, or multivariable logistic regression).

External Validity (Generalizability) : The degree to which study findings apply to the IP’s specific healthcare setting, patient demographics, and operational workflows.